An investigation for investors in MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) shares over potential securities laws violations by MabVax Therapeutics Holdings was announced
San Diego, CA -- (SBWIRE) -- 02/12/2018 -- MabVax Therapeutics Holdings, Inc is under investigation over potential violations of securities laws in connection with certain statements made by MabVax Therapeutics Holdings, Inc.
Investors who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by MabVax Therapeutics Holdings, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On January 30, 2018, MabVax Therapeutics Holdings, Inc. announced "that it received notice that the Securities and Exchange Commission ("SEC") was conducting an investigation and examination pursuant to Section 8(e) of the Securities Act of 1933, as amended, relating to certain of the Company's registration statements (and amendments thereto)."
Those who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels